Skip to content
Monday, 16 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Comuniq.EU

All eyes on EU regulator as AstraZeneca decision to be released

The name and logo of European Medicines Agency (EMA) is seen in their new building in Amsterdam, The Netherlands, 15 November 2019. As a result of the 'Brexit', the EMA was relocated to the Netherlands and officially changed its seat from London to Amsterdam on 30 March 2019. The European Medecines Agency's main task is the 'evaluation and supervision of medicinal products'. EPA-EFE/LEX VAN LIESHOUT

The European Medicines Agency (EMA) is due to provide an assessment on Thursday of the safety of Astrazeneca’s vaccine against Covid-19 after several countries temporarily suspended use of the jab over fears about side effects.

The EMA’s safety committee has been making a detailed evaluation of a small number of cases concerning blood clots occurring in recipients of the vaccine.

The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is to issue any necessary recommendations for further action after its meeting on Thursday.

Following reports of the blood clot cases, some countries in the European Union suspended use of the vaccine, further delaying already sluggish inoculation campaigns.

Many said they were waiting for guidance from the EMA.

The EMA said it was looking at available data related to all thromboembolic events reported after vaccination, including additional data provided by national health agencies.

“Rapid and thorough analysis of the available data and clinical circumstances surrounding specific cases is continuing, to determine whether the vaccine might have contributed or if events are likely to have been due to other causes,” the EMA said.

Both the EMA and the World Health Organization (WHO) recommended continuing inoculation with AstraZeneca’s vaccine until further notice, noting its benefits outweighed the risks of Covid-19.

Main Photo: The name and logo of European Medicines Agency (EMA) is seen in their building in Amsterdam, The Netherlands. EPA-EFE/LEX VAN LIESHOUT

Read more via dpa

Filed under Comuniq.EU

More from Comuniq.EU

More →